In the first six months of this year, more than 1 million seniors and people with disabilities saved $687 million on prescription drugs in the doughnut hole -- the gap between traditional and catastrophic coverage in the Part D drug benefit -- as part of the health care law, Health and Human Services plans to announce today.
That's an average of $629 per patient.
As part of the 2010 health care law, drugmakers participating in the program had to give the government a 50% break on premium drugs and 14% on generic drugs, which the government then passed on to seniors. In 2012, the coverage gap is $2,930. The health care law eliminates the doughnut hole by 2020.
"More people are benefiting from the discounts than at this point last year," said Jonathan Blum, director of the Center for Medicare. "As seniors across the country go to their pharmacies to fill prescriptions, they will automatically receive these discounts and see lower prices at the cash register."
Administrators expect to see larger savings in the second half of the year because more people will have hit their coverage limit by then. Patients with expensive drugs and treatments, such as for cancer, reach the gap early in the year. So far, the most savings were about $88 million for diabetes medications, $65 million for asthma, $58 million for autoimmune system drugs, $44 million for cholesterol-lowering drugs and $42 million for HIV infection drugs.
Some groups have raised concerns about the program. The American Action Forum, a conservative think tank, said reducing prices for Medicare beneficiaries would raise drug costs for everyone else.
No research has shown a correlation, though industry experts say it may be too soon to tell, because the discounts just began in 2011.
The following fields overflowed:
PUBDATE = 07/25/2012
To see more of USAToday.com, or to subscribe, go to http://www.usatoday.com
Copyright 2012 USA TODAY, a division of Gannett Co. Inc.